Status:
UNKNOWN
Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA
Lead Sponsor:
Hasselt University
Conditions:
Drug Use
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The results of the GX device are equivalent to standard venous blood sampling. With this study we are going to determine the prevalence in drug users with difficult venous access. On the other hand, w...
Eligibility Criteria
Inclusion
- Have recently or ever used drugs
- Older than 18 years
- Written informed consent
Exclusion
- Not being able to speak the Dutch language
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 21 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04717856
Start Date
October 21 2020
End Date
October 21 2021
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hasselt University
Diepenbeek, Belgium, 3590